Long noncoding RNA H19 mediated the chemosensitivity of breast cancer cells via Wnt pathway and EMT process

Breast cancer is still one of the major public health burdens worldwide, although there is tremendous progress in early diagnosis and treatment of breast cancer. Tamoxifen was one of the most popular endocrine therapies for early-stage estrogen receptor (ER) + breast cancer patients. However, a high...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	OncoTargets and therapy Ročník 11; s. 8001 - 8012
Hlavní autoři:	Gao, Hongli, Hao, Guijun, Sun, Yue, Li, Liye, Wang, Yukun
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	New Zealand Dove Medical Press Limited 01.01.2018 Taylor & Francis Ltd Dove Medical Press
Témata:	Analysis Antisense RNA Breast cancer Cancer cells Cancer treatment Care and treatment Cell adhesion & migration Cell culture Cell cycle Cell growth Development and progression Drug resistance Endocrine therapy Estrogens Gastric cancer Genes Hospitals Medical research Metastasis Novels Original Research Phenols (Class of compounds) Polymerase chain reaction Prognosis Proteins Public health RNA Stem cells Tamoxifen United States > US China lncRNA H19 tamoxifen-resistance breast cancer Wnt pathway EMT
ISSN:	1178-6930, 1178-6930
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!